Dattola, A. et al. 2026. Effectiveness and Safety of Deucravacitinib in Moderate-to-Severe Psoriasis: an Italian Multicenter Real-Life Study in the Lazio Region. Dermatology Practical & Conceptual. 16, 1 (Jan. 2026), 7116. DOI:https://doi.org/10.5826/dpc.1601a7116.